Firms/companies
RBI approves merger of ING Vysya with Kotak Mahindra
01 Apr 2015
The merged entity, with 1,214 branches, a wide-spread pan-India network and a combined employee strength of nearly 40,000, is now the country’s fourth largest private sector lender
Facebook violating EU privacy norms, finds Belgian study
01 Apr 2015
The BPC report finds that Facebook tracks everyone, even logged-out users or people who don’t have an account, primarily through the use of cookies and the ‘like’ button which is found on more than 13 million websites worldwide
Facebook violating EU privacy norms, finds Belgian study
01 Apr 2015
The BPC report finds that Facebook tracks everyone, even logged-out users or people who don’t have an account, primarily through the use of cookies and the ‘like’ button which is found on more than 13 million websites worldwide
Philips to sell majority stake in lighting components division for $2.8 bn
31 Mar 2015
Philips today agreed to sell a majority stake in its lighting components division to private equity investors for $2.8 billion as part of its plan to focus on the consumer health-care market
Adani meets Queensland premier amidst fresh green threat to mine project
31 Mar 2015
Adani says the mine will create 10,000 jobs and fetch $22 billion in taxes and royalties to Queensland state, but the environment group argues that the 280 sq km Carmichael mine would destry the country's ecosystem and pollute the world
Adani meets Queensland premier amidst fresh green threat to mine project
31 Mar 2015
Adani says the mine will create 10,000 jobs and fetch $22 billion in taxes and royalties to Queensland state, but the environment group argues that the 280 sq km Carmichael mine would destry the country's ecosystem and pollute the world
Teva Pharmaceutical to buy US neurology drug firm Auspex $3.5 bn
31 Mar 2015
Auspex is a biopharmaceutical company specialising in applying deuterium chemistry to known molecules to create novel therapies with improved safety and efficacy profiles
Teva Pharmaceutical to buy US neurology drug firm Auspex $3.5 bn
31 Mar 2015
Auspex is a biopharmaceutical company specialising in applying deuterium chemistry to known molecules to create novel therapies with improved safety and efficacy profiles
Latest articles
Featured articles
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.


